Bourla is not the first pharmaceutical or biotech executive to cash in on his company’s stock gains during the pandemic.
This article was originally published by Cnbc.com. Read the original article here.
Pfizer CEO sold $5.6 million of stock as company announced vaccine data that sent shares soaring
by admin 0 Comments